These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19769630)

  • 1. Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.
    Zhang N; Wu ZM; McGowan E; Shi J; Hong ZB; Ding CW; Xia P; Di W
    Cancer Sci; 2009 Dec; 100(12):2459-64. PubMed ID: 19769630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells.
    Yuan Z; Wang F; Zhao Z; Zhao X; Qiu J; Nie C; Wei Y
    PLoS One; 2011; 6(5):e20586. PubMed ID: 21655183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
    Byun JM; Lee DS; Landen CN; Kim DH; Kim YN; Lee KB; Sung MS; Park SG; Jeong DH
    Acta Oncol; 2019 Nov; 58(11):1594-1602. PubMed ID: 31257975
    [No Abstract]   [Full Text] [Related]  

  • 6. [Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line].
    Huang SG; Kong BH; Ma YY; Jiang S
    Ai Zheng; 2002 Aug; 21(8):863-7. PubMed ID: 12478894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apoptosis of drug-resistant human ovarian carcinoma cell line 3AO/cDDP induced by arsenic trioxide and its mechanism].
    Huang S; Kong B; Ma Y; Jiang S
    Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(13):911-4. PubMed ID: 12126518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSC606985 induces apoptosis, exerts synergistic effects with cisplatin, and inhibits hypoxia-stabilized HIF-1alpha protein in human ovarian cancer cells.
    Zhang N; Zhang H; Xia L; Zheng Y; Yu Y; Zhu Y; Chen G; Di W
    Cancer Lett; 2009 Jun; 278(2):139-144. PubMed ID: 19339107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment.
    Xu Y; Gu X; Gong M; Guo G; Han K; An R
    Cancer Biol Ther; 2013 Oct; 14(10):897-906. PubMed ID: 23917726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
    Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
    [No Abstract]   [Full Text] [Related]  

  • 11. Arsenic trioxide induces apoptosis in cisplatin-sensitive and -resistant ovarian cancer cell lines.
    Kong B; Huang S; Wang W; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Cui B; Yang Q
    Int J Gynecol Cancer; 2005; 15(5):872-7. PubMed ID: 16174238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
    Du YH; Ho PC
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism.
    Bowling BD; Doudican N; Manga P; Orlow SJ
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):37-43. PubMed ID: 18297286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
    Rangwala F; Williams KP; Smith GR; Thomas Z; Allensworth JL; Lyerly HK; Diehl AM; Morse MA; Devi GR
    BMC Cancer; 2012 Sep; 12():402. PubMed ID: 22963400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
    Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
    Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I
    PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L; Zhang G; Lou Z; Xu G; Zhang G
    BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
    Ghaffari SH; Bashash D; Dizaji MZ; Ghavamzadeh A; Alimoghaddam K
    Tumour Biol; 2012 Feb; 33(1):157-72. PubMed ID: 22072212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
    Ramos AM; Aller P
    Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.